Browse by topic
Subscribe to our news
[wpforms id="7833" title="false"]

Why pharma companies should utilize real-world data

Eli Lilly and Co. and Abbott have made headlines recently for using real-world evidence to prove better adherence and outcomes for its diabetes products. More pharma companies are likely to utilize real-world data to support brands as access improves. Lilly’s… Read

Social determinants of health: Delivering value with AI

Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of finding ways to analyze and… Read

4 keys to a successful medication adherence program

With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers. According to Andrea Kasprzyk, Director of Sales at AllazoHealth, “The objective of an… Read

How pharmacies can make adherence cost-effective

Incentives drive pharmacy focus on adherence As pharmacies are increasingly held to quality incentives, they are getting proactive about adherence. For example, in March 2019, Walgreen Co. started hiring pharmacists specifically tasked with helping chronic disease patients to become more… Read

How new patient data rules benefit payers

Starting next year payers may have new opportunities to collect real world data that was previously fragmented, incomplete and in some cases unavailable. According to the rules going into effect January 1, 2021 by the U.S. Department of Health and… Read

Can copay assistance increase adherence?

Besides being a financial issue for pharmaceutical companies, unfilled prescriptions can lead to poorer health outcomes, drive up overall cost of care, and can have an impact on provider performance under value-based payment models. Pharmaceutical companies often use copay assistance… Read

AllazoHealth names pharmacy benefits management leader Greg Watanabe to advisory board

AllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced that pharmacy benefits management executive Greg Watanabe will be joining the company’s Advisory Board. Mr. Watanabe has a distinguished career… Read

How smart pill bottles improve adherence

A smart pill bottle platform improved adherence and patient satisfaction among a small sample of multiple myeloma patients, according to a paper in the November 2019 issue of the Journal of Managed Care & Specialty Pharmacy. The study was conducted… Read

Dispelling the myths of artificial intelligence in healthcare

As common as artificial intelligence has become in our daily lives — from Google’s Alexa, to Facebook’s data-driven ads, to Waze’s application of driver data to find the best route — it is little understood. The public tends to believe… Read

Study with large regional payer demonstrates 5.45x greater adherence uplift using AI

Partnering with Blue Cross Blue Shield of North Carolina on a randomized control trial, AllazoHealth demonstrated a 5.5 times uplift in adherence compared with traditional programs. In addition, the study showed our artificial intelligence (AI) engine delivered over 97% accuracy… Read

COVID-19: Surveys show payers intensifying patient outreach

What do payers consider as they grapple with the medication access and adherence needs of at-risk patients during the Covid-19 pandemic? Experts at McMann Managed Markets and Syneos Health surveyed their proprietary payer advisory boards to find out. Payers respond… Read

Stay Connected

Subscribe to our emails for updates on trending topics, best practices, and advancements in healthcare and AI.